Description
Seeking men and women whose multiple myeloma has returned or gotten worse despite treatment for a study comparing investigational drug combinations.
Overview
Participants in this study will receive one of three different drug combinations, the standard treatment drug combination, the investigational drug with one other drug (Tal-D), or the investigational drug with two other drugs (Tal-DP) every 28 days.
What we're hoping for
We are comparing whether one investigational drug combination is better than another
Additional Information
ClinicalTrials.gov Identifier: NCT05455320